Brian McNamara - Haleon Plc CEO Director

HLN Stock  USD 8.24  0.02  0.24%   

Insider

Brian McNamara is CEO Director of Haleon plc
Age 58
Phone44 1932 822000
Webhttps://www.haleon.com

Haleon Plc Management Efficiency

The company has Return on Asset of 0.0428 % which means that on every $100 spent on assets, it made $0.0428 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.067 %, implying that it generated $0.067 on every 100 dollars invested. Haleon Plc's management efficiency ratios could be used to measure how well Haleon Plc manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 9.46 B in debt with debt to equity (D/E) ratio of 0.38, which is OK given its current industry classification. Haleon plc has a current ratio of 3.36, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Haleon Plc until it has trouble settling it off, either with new capital or with free cash flow. So, Haleon Plc's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Haleon plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Haleon to invest in growth at high rates of return. When we think about Haleon Plc's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Andrew WeilTeva Pharma Industries
52
Michael GrippoCatalent
55
ACGI BScHUTCHMED DRC
70
Sanjeev SethiViatris
57
Ronit SatchiFainaroTeva Pharma Industries
48
Abbas HussainTeva Pharma Industries
55
Wafaa MamilliZoetis Inc
57
CS CGPHUTCHMED DRC
70
Thomas VadakethBausch Health Companies
61
Robert CouryViatris
63
Scott FergusonElanco Animal Health
46
Deepak MBADr Reddys Laboratories
49
Z MahdaviCatalent
N/A
Lynn KiefferEmergent Biosolutions
N/A
CA BEcHUTCHMED DRC
57
Melissa TrombettaViatris
N/A
Julien MeissonnierCatalent
N/A
Mukesh RathiDr Reddys Laboratories
45
Sanjay BTechDr Reddys Laboratories
56
D HaleBausch Health Companies
34
Melissa DownsLantheus Holdings
N/A
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom. Haleon Plc operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 22000 people. Haleon plc (HLN) is traded on New York Stock Exchange in USA. It is located in The Heights, Weybridge, United Kingdom, KT13 0NY and employs 25,408 people. Haleon Plc is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Haleon plc Leadership Team

Elected by the shareholders, the Haleon Plc's board of directors comprises two types of representatives: Haleon Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Haleon. The board's role is to monitor Haleon Plc's management team and ensure that shareholders' interests are well served. Haleon Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Haleon Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
Keith Choy, President Pacific
Tamara Rogers, Chief Officer
Lisa Paley, President America
Brian McNamara, CEO Director
Bjarne Tellmann, General Counsel
Bart Derde, Head Chain
Franck Riot, Chief Officer
Bjorn Timelin, Head Strategy
Tobias Hestler, CFO Director
Amy Landucci, Head Technology
Namrata Patel, Chief Officer
Jooyong Lee, Head CEO
Mairead Nayager, Chief Officer
Teri Lyng, Head Sustainability
Sonya Ghobrial, Head Relations
Ed Petter, Chief Officer
Filippo Lanzi, President LatAm

Haleon Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Haleon Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Haleon plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Haleon Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Haleon Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Haleon Plc Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Haleon plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
To learn how to invest in Haleon Stock, please use our How to Invest in Haleon Plc guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Haleon Stock analysis

When running Haleon Plc's price analysis, check to measure Haleon Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haleon Plc is operating at the current time. Most of Haleon Plc's value examination focuses on studying past and present price action to predict the probability of Haleon Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haleon Plc's price. Additionally, you may evaluate how the addition of Haleon Plc to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Commodity Directory
Find actively traded commodities issued by global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Haleon Plc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Haleon Plc. If investors know Haleon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Haleon Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Haleon plc is measured differently than its book value, which is the value of Haleon that is recorded on the company's balance sheet. Investors also form their own opinion of Haleon Plc's value that differs from its market value or its book value, called intrinsic value, which is Haleon Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Haleon Plc's market value can be influenced by many factors that don't directly affect Haleon Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Haleon Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Haleon Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Haleon Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.